SARS CoV 2 News and Research

RSS

NHS doctors say UK not prepared for coronavirus outbreak

The coronavirus disease (COVID-19) outbreak has spread dramatically around the globe, infecting more than 92,000 people and killing more than 3,000.

3 Mar 2020

The changing face of the COVID-19 epidemic

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus, which hit China with the disease now named COVID-19 in December 2019 and has since spread to over 70 countries, has caused over 90,000 cases, and 3,117 fatalities, with 95% or more of both being in China.

2 Mar 2020

Australia's first coronavirus death puts country on alert

The rapid spread of the coronavirus outside China has intensified as the total number of infections globally has topped 90,000, and the number of deaths reached more than 3,000. The sudden surge of cases in Italy, Iran, and South Korea have left health officials concerned about the magnitude of the coronavirus disease (COVID-19) outbreak.

2 Mar 2020

UK races to tackle coronavirus spread

The coronavirus disease (COVID-19) outbreak spiked dramatically on Sunday, with more countries reporting additional cases. The deadly virus has added 13 more confirmed cases in the United Kingdom, with Scotland reporting its first case. Health officials are racing to identify people who are unaware they may have been exposed.

1 Mar 2020

Drug for Ebola and MERS effective against COVID-19

A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.

1 Mar 2020

Coronavirus pathology findings shows how the disease affects the body

Coronavirus disease (COVID-19) is spreading rapidly across the globe. Since COVID-19 is a new disease, scientists are racing to determine the nature of the virus and how it affects the human body. Now, a team of scientists, have shed light on how the virus affects the respiratory tract. The study provides essential information and descriptions of the early phase pathology of COVID-19 infection.

1 Mar 2020

Researchers show how investigational antiviral drug stops coronavirus

A team of academic and industry researchers is reporting new findings about how exactly an investigational antiviral drug stops coronaviruses.

28 Feb 2020

New compounds may help stop the spread of the coronavirus

Amid the global health crisis of the coronavirus (COVID-19), scientists from around the world are racing to find a treatment to stop the deadly virus. The sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across 46 countries, infecting more than 82,000 and killing more than 2,800 people.

26 Feb 2020

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, today announced the launch of a Pilot investigator-initiated clinical trial with APN01, a recombinant human angiotensin-converting enzyme 2, to treat patients with severe coronavirus infection in the People's Republic of China.

26 Feb 2020

Coronavirus vaccine trials commence

The coronavirus disease (COVID-19) outbreak has swept the world, killing 2,770 people and infecting more than 81,000. Amid the health crisis, scientists from across the globe are racing to develop novel therapies and vaccines in the hope of stemming the spread of the deadly virus.

26 Feb 2020

HKUST scientists provide leads for guiding research towards COVID-19 vaccine development

A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.

26 Feb 2020

Promega's custom manufacturing capabilities support rapid development of Logix Smart COVID-19 Test

Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc.

From Promega Corporation 26 Feb 2020

Clinical trial to evaluate safety, efficacy of remdesivir in adults with COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.

25 Feb 2020

Coronavirus incubation period could be 27 days, longer than previously thought

Over the past weeks, health officials around the globe traced and advised suspected contacts of people with the coronavirus disease (COVID-19) to isolate themselves for 14 days, the incubation period of the disease.

24 Feb 2020

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

21 Feb 2020

Vaccine for COVID-19 coronavirus could soon be a reality

A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.

19 Feb 2020

Study identifies new CoV responsible for the Wuhan outbreak

The 2019 novel coronavirus causes fatal pneumonia that has claimed over 1300 lives, with more than 52000 confirmed cases of infection by February 13, 2020, all in the span of just over a month.

18 Feb 2020

Experimental antiviral prevents MERS-CoV in rhesus macaques

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists.

13 Feb 2020

Study finds no evidence of intrauterine vertical transmission of COVID-19 infection

There is currently no evidence that the 2019 novel coronavirus disease (COVID-19) causes severe adverse outcomes in neonates or that it can pass to the child while in the womb, according to a small observational study of women from Wuhan, China, who were in the third trimester of pregnancy and had pneumonia caused by COVID-19.

12 Feb 2020

2019 coronavirus virus officially named COVID-19

The novel coronavirus disease, which has spread from China to 24 other countries around the globe, has received its official name – COVID-19, the World Health Organization (WHO) said.

12 Feb 2020